Molecular mimicry and autoimmunity

New England Journal of Medicine

Volumn 341, Issue 27, 1999, Pages 2068-2074

  Albert, Lori J ^a,b   Inman, Robert D ^a,b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AUTOANTIGEN; AZATHIOPRINE; CYCLOSPORIN; DIURETIC AGENT; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; VASODILATOR AGENT;

AMINO ACID SEQUENCE; ANTIGEN RECOGNITION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CROSS REACTION; EXPERIMENTAL MODEL; HUMAN; INFECTION; MOLECULAR MIMICRY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; MOLECULAR MIMICRY; SEQUENCE HOMOLOGY, AMINO ACID; T-LYMPHOCYTES;

EID: 0033619915     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199912303412707     Document Type: Review

References (54)

1. Ohashi PS, Ochen S, Buerki K, et al. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991;65:305-17.
2. Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 1991;65:319-31.
3. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 1990;322:1555-60.
4. Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, Tobin AJ. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992;89:283-92.
5. Tian J, Lehmann PV, Kaufman DL. T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J Exp Med 1994;180:1979-84.
6. Endl J, Otto H, Jung G, et al. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J Clin Invest 1997;99:2405-15.
7. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994;94:2125-9.
8. Richter W, Mertens T, Schoel B, et al. Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with coxsackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies. J Exp Med 1994;180:721-6.
9. Albani S, Keystone EC, Nelson JL, et al. Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis. Nat Med 1995;1:448-52.
10. Cohen IR, Holoshitz J, van Eden W, Frenkel A. T lymphocyte clones illuminate pathogenesis and affect therapy of experimental arthritis. Arthritis Rheum 1985;28:841-5.
11. Evans CF, Horwitz MS, Hobbs MV, Oldstone MB. Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease. J Exp Med 1996;184: 2371-84.
12. Lipton HL. Theiler's virus infection in mice: an unusual biphasic diseases process leading to demyelination. Infect Immun 1975;11:1147-55.
13. Yong Z, Zhang JJ, Schaack T, Chen S, Nakayama A, Yu DTY. A monoclonal anti-HLA-B27 antibody which is reactive with a linear sequence of the HLA-B27 protein is useful for the study of molecular mimicry. Clin Exp Rheumatol 1989;7:513-9.
14. Schwimmbeck PL, Yu DTY, Oldstone MB. Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome: molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med 1987;166:173-81.
15. Scofield RH, Warren WL, Koelsch G, Harley JB. A hypothesis for the HLA-B27 immune dysregulation in spondyloarthropathy: contributions from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution. Proc Natl Acad Sci U S A 1993;90:9330-4.
16. Tsuchiya N, Husby G, Williams RC Jr. Studies of humoral and cell-mediated immunity to peptides shared by HLA-27.1 and Klebsiella pneumoniae nitrogenase in ankylosing spondylitis. Clin Exp Immunol 1989;76: 354-60.
17. Singh B, Dillion T, Lauzon J, Fraga E, Russell AS. Tolerance to the HLA-B27 and Klebsiella pneumoniae crossreactive epitope in mice transgenic for HLA-B2705 and human beta 2-microglobulin. J Rheumatol 1994;21:670-4.
18. Luo G, Fan J-L, Seetharamaiah GS, et al. Immunization of mice with Yersinia enterocolitica leads to the induction of antithyrotropin receptor antibodies. J Immunol 1993;151:922-8.
19. Luo G, Seetharamaiah GS, Niesel DW, et al. Purification and characterization of Yersinia enterocolitica envelope proteins which induce antibodies that react with human thyrotropin receptor. J Immunol 1994;152: 2555-61.
20. Kersh GJ, Allen PM. Essential flexibility in the T-cell recognition of antigen. Nature 1996;380:495-8.
21. Hausmann S, Wucherpfennig KW. Activation of autoreactive T cells by peptides from human pathogens. Curr Opin Immunol 1997;9:831-8.
22. Ohashi PS. T cell selection and autoimmunity: flexibility and tuning. Curr Opin Immunol 1996;8:808-14.
23. Goodnow CC. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci U S A 1996;93:2264-71.
24. Amsen D, Kruisbeck AM. Thymocyte selection: not by TCR alone, Immunol Rev 1998;165:209-29.
25. Wang R, Nelson A, Kimachi K, Grey HM, Farr AG. The role of peptides in thymic positive selection of class II major histocompatibility complex-restricted T cells. Proc Natl Acad Sci USA 1998;95:3804-9.
26. Motyka B, Teh H-S. Naturally occurring low affinity peptide/MHC class I ligands can mediate negative selection and T cell activation. J Immunol 1998;160:77-86.
27. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993;11:729-66.
28. Parker DC. T cell-dependent B cell activation. Annu Rev Immunol 1993;11:331-60.
29. Behar SM, Porcelli SA. Mechanisms of autoimmune disease induction: the role of the immune response to microbial pathogens. Arthritis Rheum 1995;38:458-76.
30. Horvitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 1998;4:781-5.
31. Roudier C, Auger I, Roudier J. Molecular mimicry reflected through database screening: serendipity or survival strategy? Immunol Today 1996; 17:357-8.
32. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995;80:695-705.
33. Hemmer B, Vergelli M, Gran B, et al. Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology. J Immunol 1998;160:3631-6.
34. Hemmer B, Fleckenstein BT, Vergelli M, et al. Identification of high potency microbial and self ligands for a human autorcactive class II-restricted T cell clone. J Exp Med 1997;185:1651-9.
35. von Herrath MG, Guerder S, Lewicki H, Flavell RA, Oldstone MBA. Coexpression of B7-1 and viral ("self") transgenes in pancreatic beta cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity 1995;3:727-38.
36. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992; 358:155-7.
37. Damian RT. Molecular mimicry: antigen sharing by parasite and host and its consequences. Am Nat 1964;98:129-49.
38. Andersen O, Lygner PE, Bergstrom T, Andersson M, Vahlne A. Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol 1993;240:417-22.
39. Streilein JW, Dana MR, Ksander BR. Immunity causing blindness: five different paths to herpes stromal keratins. Immunol Today 1997;18: 443-9.
40. Zhao Z-S, Granucci F, Yeh L, Schaffer PA, Cantor H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 1998;279:1344-7.
41. Bachmaier K, Neu N, de la Maza LM, Pal S, Hessel A, Penninger JM. Chlamydia infections and heart disease linked through antigenic mimicry. Science 1999;283:1335-9.
42. Zabriskie JB, Freimer EH. An immunological relationship between the Group A streptococcus and mammalian muscle. J Exp Med 1966;124: 661-78.
43. Dale JB, Beachey EH. Epitopes of streptococcal M protein shared with cardiac myosin. J Exp Med 1985;162:583-91.
44. Kaplan MH, Dallenbach FD. Immunologic studies of heart tissue. III. Occurrence of bound gamma globulin in auricular appendages from rheumatic hearts: relationship to certain histopathologic features of rheumatic heart disease. J Exp Med 1961;113:1-16.
45. Huber SA, Cunningham MW. Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsackieviral myocarditis. J Immunol 1996;156:3528-34.
46. Adderson EE, Shikhman AR, Ward KE, Cunningham MW. Molecular analysis of polyreactivc monoclonal antibodies from rheumatic carditis: human anti-N-acetylglucosamine/anti-myosin antibody V region genes. J Immunol 1998;161:2020-31.
47. Gross DM, Forsthuber T, Tary-Lehmann M, et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lymc arthritis. Science 1998;281:703-6.
48. Jones DB, Armstrong NW. Coxsackie virus and diabetes revisited. Nat Med 1995;1:284.
49. Atkinson MA, Bowman MA, Kao K-J, et al. Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes. N Engl J Med 1993;329:1853-8.
50. Moon RY, Greene MG, Rehe GT, Katona IM. Poststreptococcal reactive arthritis in children: a potential predecessor of rheumatic heart disease. J Rheumatol 1995;22:529-32.
51. Locht H, Kihlstrom E, Lindstrom FD. Reactive arthritis after Salmonella among medical doctors - study of an outbreak. J Rheumatol 1993; 20:845-8.
52. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995;333:269-75.
53. Steere AC, Sikand VK, Meurice F, et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N Engl J Med 1998;339:209-15.
54. Sigal LH, Zahradnik JM, Lavin P, et al. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. N Engl J Med 1998;339:216-22. [Erratum, N Engl J Med 1998;339: 571.]